Related Experiment Video
Updated: Jun 2, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Retromer disruption promotes amyloidogenic APP processing
Christopher P Sullivan1, Anthony G Jay, Edward C Stack
1Geriatric Research, Education, and Clinical Center, Edith Nourse Rogers Memorial Veteran's Administration Hospital, Bedford, MA, USA. chris.sullivan@va.gov
Abstract:
Retromer deficiency has been implicated in sporadic AD and animals deficient in retromer components exhibit pronounced neurodegeneration. Because retromer performs retrograde transport from the endosome to the Golgi apparatus and neuronal Aβ is found in late endosomal compartments, we speculated that retromer malfunction might enhance amyloidogenic APP processing by promoting interactions between APP and secretase enzymes in late endosomes. We have evaluated changes in amyloid precursor protein (APP) processing and trafficking as a result of disrupted retromer activity by knockdown of Vps35, a vacuolar sorting protein that is an essential component of the retromer complex. Knocking down retromer activity produced no change in the quantity or cellular distribution of total cellular APP and had no affect on internalization of cell-surface APP. Retromer deficiency did, however, increase the ratio of secreted Aβ42:Aβ40 in HEK-293 cells over-expressing APP695, due primarily to a decrease in Aβ40 secretion. Recent studies suggest that the retromer-trafficked protein, Wntless, is secreted at the synapse in exosome vesicles and that these same vesicles contain Aβ. We therefore hypothesized that retromer deficiency may be associated with altered exosomal secretion of APP and/or secretase fragments. Holo-APP, Presenilin and APP C-terminal fragments were detected in exosomal vesicles secreted from HEK-293 cells. Levels of total APP C-terminal fragments were significantly increased in exosomes secreted by retromer deficient cells. These data suggest that reduced retromer activity can mimic the effects of familial AD Presenilin mutations on APP processing and promote export of amyloidogenic APP derivatives.
Insights
Retromer deficiency impairs cellular transport, increasing amyloidogenic Aβ42:Aβ40 ratios and promoting the export of harmful APP fragments via exosomes. This suggests retromer dysfunction contributes to Alzheimer's disease pathogenesis.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Retromer deficiency is linked to sporadic Alzheimer's disease (AD) and neurodegeneration.
- Retromer facilitates retrograde transport, crucial for endosome-to-Golgi pathways.
- Amyloid precursor protein (APP) and its processing occur in late endosomes.
Purpose of the Study:
- To investigate the impact of retromer deficiency on amyloid precursor protein (APP) processing and trafficking.
- To determine if disrupted retromer function enhances amyloidogenic APP processing.
- To examine the role of retromer in the exosomal secretion of APP fragments.
Main Methods:
- Knockdown of Vps35, an essential retromer component, to disrupt retromer activity.
- Quantification of total APP and assessment of cell-surface APP internalization.
- Measurement of secreted amyloid-beta (Aβ) peptides (Aβ42, Aβ40) and analysis of exosomal APP C-terminal fragments.
Main Results:
- Retromer deficiency did not alter total APP levels or internalization.
- A significant increase in the Aβ42:Aβ40 ratio was observed due to decreased Aβ40 secretion.
- Levels of APP C-terminal fragments were elevated in exosomes from retromer-deficient cells.
Conclusions:
- Reduced retromer activity enhances amyloidogenic APP processing, mimicking familial AD mutations.
- Retromer deficiency promotes the exosomal secretion of amyloidogenic APP derivatives.
- These findings implicate retromer dysfunction in Alzheimer's disease pathogenesis.
More Related Videos
Related Concept Videos
Export of Misfolded Proteins out of the ER
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
The Unfolded Protein Response
Alzheimer Disease ll: Pathophysiology
Regulation of the Unfolded Protein Response

